New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
10:16 EDTWTW, AVP, TRLA, EXPE, MACKOptions with decreasing implied volatility: MACK EXPE TRLA AVP WTW
News For MACK;EXPE;TRLA;AVP;WTW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
January 22, 2015
13:05 EDTAVPAvon Products has been in discussions with TPG Capital, dealReporter says
Subscribe for More Information
13:03 EDTAVPAvon Products moves up on comments by dealReporter
January 21, 2015
12:07 EDTTRLAUBS Group AG reports 7.01% passive stake in Trulia
January 20, 2015
14:09 EDTEXPEOrbitz jumps after Bloomberg says company may be exploring sale
Shares of online travel agency Orbitz Worldwide (OWW) are jumping after Bloomberg reported that the company is exploring the possibility of selling itself. In a note to investors on January 7, research firm FBR Capital wrote that the company could be acquired for over $10 per share, WHAT'S NEW: Orbitz is exploring a potential sale and private equity firms have expressed interest in acquiring the online travel agency, Bloomberg reported today. ANALYST VIEW: On January 7, research firm FBR Capital estimated that Orbitz could be acquired for $10.27 per share. The firm noted that a trade publication, Tnooz.com, had reported that Orbitz could be considering selling itself. Expedia (EXPE) and Priceline (PCLN) could each pay a premium of 30%-plus for Orbitz and still see their profits rise from the acquisition, FBR added. It kept a $9 price target and Outperform rating on Orbitz. PRICE ACTION: In mid-afternoon trading, Orbitz climbed 69c, or 7.5%, to $9.85.
13:51 EDTEXPEOrbitz draws private equity interest as sale explored, Bloomberg says
Orbitz Worldwide (OWW) is working with an adviser to contact potential buyers and has drawn interest from private-equity funds and "other Internet companies," according to Bloomberg, citing people with knowledge of the matter. Shares of Orbitz are up over 10% after the report, while several other names in the online travel space, such as Priceline (PCLN), Expedia (EXPE), and TripAdvisor (TRIP) are also moving. Reference Link
13:43 EDTEXPEExpedia, TripAdvisor tick higher after report on Orbitz sale exploration
Subscribe for More Information
08:16 EDTMACKMerrimack data of Phase 3 MM-398 NAPOLI-1 study supports development programs
Merrimack Pharmaceuticals (MACK) announced that additional analyses were presented on January 16, 2015 from the Phase 3 NAPOLI-1 study of MM-398, also known as nal-IRI, in patients with metastatic pancreatic cancer previously treated with gemcitabine-based therapy. Merrimack and Baxter International's (BAX) biopharmaceutical business are collaborating on the development and commercialization of MM-398 outside of the United States and Taiwan. PharmaEngine holds the rights to commercialize MM-398 in Taiwan. Additionally, Merrimack presented preclinical and clinical data from studies of its investigational agents MM-141 and MM-151 in pancreatic and colorectal cancer, respectively. An investigator-sponsored study of MM-398 in colorectal cancer was also presented. The extended analyses for the global NAPOLI-1 Phase 3 trial presented at ASCO GI support the robustness of the overall survival benefit of MM-398 in combination with 5-fluorouracil, or 5-FU, and leucovorin presented in June 2014, at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer, or ESMO GI. The primary analysis, presented at ESMO GI, demonstrated a statistically significant advantage in overall survival with an unstratified hazard ratio of 0.67, and a median of 6.1 months for the combination of MM-398 plus 5-FU and leucovorin compared to 4.2 months in the control arm.
06:09 EDTAVPAvon Products implied volatility of 76 at upper end of index mean range
Subscribe for More Information
January 16, 2015
08:44 EDTEXPEExpedia may have to pay $180M for Travelocity, says FBR Capital
Subscribe for More Information
07:21 EDTEXPESabre sale of Travelocity to Expedia would be win for both, says Oppenheimer
Subscribe for More Information
January 15, 2015
10:29 EDTAVPOptions with increasing implied volatility
Subscribe for More Information
07:59 EDTMACKAmerican Society of Clinical Oncology to hold a symposium
Subscribe for More Information
07:25 EDTWTWWeight Watchers price target lowered to $20 from $24 at Credit Suisse
Subscribe for More Information
January 14, 2015
11:28 EDTAVPStocks with call strike movement; RIG AVP
Transocean (RIG) May 17 call option implied volatility increased 11% to 80, Avon Products (AVP) April 9 call option implied volatility increased 4% to 65 according to IVolatility.
10:39 EDTAVPOptions with increasing implied volatility
Subscribe for More Information
07:37 EDTMACKJPMorgan to hold a conference
Subscribe for More Information
January 12, 2015
10:40 EDTAVPStocks with call strike movement; AVP DNR
Avon Products (AVP) April 10 call option implied volatility increased 4% to 63, Denbury Resources (DNR) June 8 call option implied volatility increased 3% to 63 according to IVolatility.
10:24 EDTAVPOptions with increasing implied volatility
Options with increasing implied volatility: TLM GREK ARNA AVP
07:17 EDTMACKJPMorgan to hold a conference
Subscribe for More Information
05:55 EDTAVPStocks with implied volatility movement; RSH AVP
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use